Professional Documents
Culture Documents
ANTIBIOTIC
ANTIBIOTIC
USE IN SURGERY
BY DR. MAIMUNA MUHAMMAD IBRAHIM
OUTLINE
• INTRODUCTION
• GENERAL PRINCIPLES OF ANTIBIOTICS USE
• ANTIBIOTIC PROPHYLAXIS
• THERAPEUTIC ANTIBIOTIC USE I
• NDISCRIMINATE USE OF ANTIBIOTICS
• TOXICITY OF ANTIBIOTICS
• CONCLUSIONS
INTRODUCTION
DEFINITION
ANTIBIOTICS ARE PRODUCTS OF VARIOUS SPECIES OF MICROORGANISMS
INCLUDING BACTERIA, FUNGI AND ACTINOMYCETES THAT SUPPRESS GROWTH OR
KILL OTHER MICRO-ORGANISMS
ANTIMICROBIAL (ANTIBACTERIAL) IS A TERM USE TO INCLUDING PURELY
SYNTHETIC AGENTS SUCH AS:
• SULPHONAMIDES
• QUINOLONES
• THE GOAL OF THERAPY IS TO ACHIEVE LEVELS OF ANTIBIOTIC AT SITE OF
INFECTION THAT EXCEED THE MINIMUM INHIBITORY CONCENTRATION FOR THE
PATHOGENS PRESENT.
• MILD INFECTION CAN BE TREATED AT THE OUTPATIENT WITH ORAL ANTIBIOTICS.
• FOR SEVERE INFECTION INTRAVENOUS ANTIBIOTICS WILL BE MOST
APPROPRIATE.
• FOR MOST SURGICAL INFECTION THERE IS NO SPECIFIC DURATION OF
ANTIBIOTIC KNOW TO BE IDEAL.
• ANTIBIOTICS ARE GENERALLY BELIEVED TO SUPPORT
• HISTORICAL PERSPECTIVE
• EARLY 19TH CENTURY - LOUIS PASTEUR DISCOVERED THAT CERTAIN
SAPROPHYTIC BACTERIA CAN KILL ANTHRAX BACILLI.
• 1928 - ALEXANDER FLEMING DERIVED PENICILLIN FROM PENICILLIUM NOTATUM.
• 1939 - TYROTHRICIN WAS ISOLATED FROM CERTAIN SOIL BACTERIA BY RENE
DUBOS.
• 1944 - SELMAN WAKSMAN DERIVED STREPTOMYCIN FROM ACTINOMYCETES.
MODE OF ACTION
BACTERIOSTATIC
• CHLORAMPHENICOL
• TETRACYCLINES
• MACROLIDES
• SULPHONAMIDE
• CLINDAMYCIN
BACTERICIDAL
• PENICILLIN
• AMINOGLYCOSIDE
• CEPHALOSPORIN
• METRONIDAZOLE
• QUINOLONES
ESTABLISH A CLINICAL DIAGNOSIS AND THE NEED FOR ANTIBIOTICS BASE ON HISTORY AND PHYSICAL EXAMINATION
DETERMINE THE URGENCY OF THE SITUATION
• NON-URGENT SITUATION: MILD INFECTION OR CHRONIC INFECTION
• URGENT SITUATION:- SUSPECTED SEVERE INFECTION
OBTAIN AN APPROPRIATE CLINICAL SPECIMENS FOR EXAMINATION, CULTURE AND SENSITIVITY
REMOVE BARRIER TO CURE BY
• DEBRIDEMENT
• SEQUESTRECTOMY
• I&D
• GOOD WOUND CARE
DETERMINE THE MOST LIKELY ORGANISM CAUSING THE INFECTION
• FOCUS OF INFECTION
• AGE
• EPIDEMIOLOGIC FEATURES
• PRIOR CULTURE DATA
IF MULTIPLE ANTIBIOTICS ARE AVAILABLE TO TREAT PATHOGEN, CHOOSE THE BEST AGENT
• PRIOR ANTIBIOTIC ALLERGIES
• ANTIBIOTIC PENETRATION
• POTENTIAL SIDE EFFECTS
• MEDICAL CONDITION OF THE PATIENT
ANTIBIOTIC COMBINATION CAN BE CONSIDERED TO ACHIEVE SYNERGISM
ASSESS EFFECTIVENESS OF ANTIBIOTIC THERAPY
- CLINICAL ASSESSMENT -
• TEMPERATURE - 48 HRS 4BC ANTIBIOTICS
• INFLAMMATORY MARKERS - SIGNIF. ICRP < 25 % FROM THE BASELINE WITHIN 24 HRS.
• CONTAGIOUSNESS OF PATIENT -
BC 24 HRS.
BS 5 DAYS
INITIAL THERAPY MAY NEED MODIFICATION AFTER CULTURE RESULTS ARE AVAILABLE
• MODIFICATION NOT NECESSARY IF THERE IS SIGNIFICANT RELIEF OF SYMPTOMS
• NARROW SPECTRUM OF ANTIBIOTICS SHOULD BE USED (TO DECREASE THE RISK OF COLONIZATION)
• NEGATIVE CULTURES
DANGERS OF INDISCRIMINATE USE